We'll start big, with $66 billion pharma firm Amgen (AMGN). Amgen has been a strong performer in the last year, rallying more than 28% over the trailing 12 months. But that rally may be far from over if the price setup in shares holds true.
That's because Amgen is currently forming an ascending triangle pattern, a bullish setup that's formed by horizontal resistance to the upside (at $90, in this case) and uptrending support below shares. As AMGN bounces between those two technical barriers, it's getting squeezed closer and closer to a breakout above resistance. When that breakout above $90 happens, traders have a buy signal for this big pharmaceutical stock.
It's important not to be early on this Amgen trade. Shares have reversed off of $90 resistance the last three times they attempted to move through it. It'll take a close above that $90 level to indicate that the Amgen trade is on.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV